Intuitive Surgical, Inc. (ISRG) Bundle
An Overview of Intuitive Surgical, Inc. (ISRG)
General Overview of Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical, Inc. (ISRG) was founded in 1995 and is headquartered in Sunnyvale, California. The company is best known for its innovative robotic surgical systems, primarily the da Vinci Surgical System, which enables surgeons to perform minimally invasive surgeries with enhanced precision and control. As of 2024, Intuitive Surgical has established a significant presence in the healthcare market, with a global installed base of approximately 9,539 da Vinci systems, up from 8,285 in 2023.
The company offers a range of products and services, including:
- da Vinci Surgical Systems
- Instruments and accessories for robotic surgery
- Service and support for installed systems
In 2024, Intuitive Surgical reported total sales of $5.94 billion for the nine-month period ending September 30, 2024, reflecting a 14% increase compared to $5.20 billion in the same period of 2023.
Company's Financial Performance in the Latest Financial Reports
For the third quarter of 2024, Intuitive Surgical achieved record-breaking revenues, with total revenue increasing by 17% to $2.04 billion, compared to $1.74 billion for the same quarter in 2023. This growth was primarily driven by an 18% increase in instruments and accessories revenue, which reached $1.26 billion, and a 17% increase in systems revenue, totaling $445 million.
Key financial highlights for the nine months ended September 30, 2024, include:
- Total revenue: $5.94 billion (up 14% from $5.20 billion in 2023)
- Product revenue: $4.98 billion (up 15% from $4.33 billion in 2023)
- Service revenue: $960 million (up 11% from $863 million in 2023)
- Operating income: $1.61 billion (up 22% from $1.32 billion in 2023)
- Net income: $1.64 billion (up 37% from $1.19 billion in 2023)
In terms of system placements, the company placed a total of 1,033 da Vinci surgical systems during the nine months ended September 30, 2024, compared to 955 systems in the same period of 2023.
Intuitive Surgical as a Leader in the Industry
Intuitive Surgical is recognized as a leader in the robotic-assisted surgical industry, with a strong focus on innovation and customer satisfaction. The company has consistently invested in research and development, with R&D expenses totaling $850.6 million for the nine months ended September 30, 2024. The growth in da Vinci procedures, which saw approximately 670,000 surgeries performed in Q3 2024 (an 18% increase year-over-year), underscores the increasing adoption of robotic-assisted surgery globally.
Intuitive Surgical's commitment to expanding its market presence is evident in its ongoing efforts to enhance the capabilities of its surgical systems and broaden its product offerings. The company continues to explore new opportunities in international markets, contributing to its robust growth trajectory and solidifying its position as a key player in the healthcare sector.
Mission Statement of Intuitive Surgical, Inc. (ISRG)
Mission Statement of Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical, Inc. is dedicated to advancing the field of robotic-assisted surgery, aiming to enhance the quality of surgical care and improve patient outcomes. The company's mission statement emphasizes a commitment to innovation, quality, and comprehensive support for healthcare providers.
Core Component 1: Innovation
Intuitive Surgical prioritizes innovation in its product development, focusing on the da Vinci surgical systems and Ion endoluminal systems. The company reported a total revenue of $2.04 billion for the three months ended September 30, 2024, which reflects an increase of 17% compared to the same period in 2023. This growth is indicative of the market's positive response to their innovative offerings.
| Key Innovations | Impact on Revenue | Procedure Growth |
|---|---|---|
| da Vinci Surgical System | $1.71 billion in product revenue for Q3 2024 | 670,000 procedures performed, up 18% YoY |
| Ion Endoluminal System | $328.9 million in service revenue for Q3 2024 | 25,000 procedures performed, up 73% YoY |
Core Component 2: Quality
Quality is a cornerstone of Intuitive Surgical's mission. The company ensures that its products meet rigorous standards, which is reflected in a gross profit margin of 67.4% for the three months ended September 30, 2024. This commitment to quality contributes to their strong market position and customer trust.
| Financial Metrics | Q3 2024 | Q3 2023 |
|---|---|---|
| Total Revenue | $2.04 billion | $1.74 billion |
| Gross Profit | $1.37 billion | $1.17 billion |
| Operating Income | $577 million | $466 million |
Core Component 3: Comprehensive Support
Intuitive Surgical's mission highlights the importance of providing comprehensive support to its customers. This is evident in their service revenue, which reached $329 million for the three months ended September 30, 2024, marking a 12% increase from the previous year. The company's extensive training and support programs enhance the efficacy of their surgical systems.
| Support Metrics | Q3 2024 | Q3 2023 |
|---|---|---|
| Service Revenue | $329 million | $293 million |
| Installed Base of Systems | 9,539 systems | 8,285 systems |
| System Placements | 379 systems placed | 312 systems placed |
Vision Statement of Intuitive Surgical, Inc. (ISRG)
Vision Statement Overview
Intuitive Surgical, Inc. (ISRG) envisions a future where robotic-assisted surgery is the standard of care across multiple surgical specialties. The company aims to enhance the quality of surgical procedures, improve patient outcomes, and increase access to minimally invasive surgical options globally.
Commitment to Innovation
Innovation is at the core of Intuitive Surgical's vision. The company is committed to advancing its da Vinci surgical systems and Ion endoluminal systems. As of September 30, 2024, the company placed 379 da Vinci surgical systems, a significant increase from 312 systems in the same period of the previous year. This growth reflects the demand for innovative surgical solutions that improve surgical precision and patient recovery times.
Global Accessibility
ISRG aims to make robotic-assisted surgery accessible worldwide. The company reported approximately 670,000 da Vinci procedures performed in the third quarter of 2024, marking an 18% increase from 567,000 procedures in the same quarter of 2023. This increase demonstrates the company’s efforts to expand its global footprint and enhance access to advanced surgical technologies.
Patient-Centric Approach
At the heart of Intuitive Surgical's vision is a patient-centric approach. The company emphasizes improving patient outcomes through minimally invasive procedures. In the third quarter of 2024, the revenue from instruments and accessories rose by 18% to $1.26 billion, driven by higher da Vinci procedure volumes.
Focus on Education and Training
ISRG is dedicated to educating and training surgeons and healthcare professionals on the use of its robotic systems. The company believes that effective training is essential for maximizing the potential of its technologies. The installed base of da Vinci systems grew to approximately 9,539 units by September 30, 2024, reflecting the increasing adoption and trust in robotic-assisted surgeries.
Financial Performance and Growth Metrics
Intuitive Surgical's financial performance underscores its vision. For the three months ended September 30, 2024, total revenue increased by 17% to $2.04 billion compared to $1.74 billion for the same period in 2023. This growth was driven by an 18% increase in instruments and accessories revenue and a 17% increase in systems revenue.
| Metric | Q3 2024 | Q3 2023 | Change (%) |
|---|---|---|---|
| Total Revenue | $2.04 billion | $1.74 billion | 17% |
| Instruments and Accessories Revenue | $1.26 billion | $1.07 billion | 18% |
| Systems Revenue | $445 million | $379 million | 17% |
| da Vinci Procedures | 670,000 | 567,000 | 18% |
| da Vinci System Placements | 379 | 312 | 21% |
| Installed Base of da Vinci Systems | 9,539 | 8,285 | 15% |
Future Aspirations
Looking ahead, Intuitive Surgical aims to continue its trajectory of growth and innovation. The company plans to expand its product offerings and enhance its systems to meet the evolving needs of healthcare providers and patients. With a robust pipeline of new technologies and a commitment to improving surgical outcomes, ISRG is poised to lead the field of robotic-assisted surgery.
Core Values of Intuitive Surgical, Inc. (ISRG)
Core Value: Innovation
Innovation is vital to Intuitive Surgical, Inc. as it drives the development of advanced robotic-assisted surgical systems like the da Vinci Surgical System. The company continually invests in research and development to enhance surgical outcomes and improve patient care.
In 2024, Intuitive Surgical reported $286 million in research and development expenses for the third quarter, a 15% increase from $249.4 million in the same period in 2023. This commitment supports the introduction of new technologies, such as the next-generation da Vinci 5 system, which was launched to meet the growing demand for minimally invasive surgery.
Additionally, the company has seen an increase in the utilization of its systems, with approximately 670,000 da Vinci procedures performed during Q3 2024, reflecting an 18% growth compared to the previous year.
Core Value: Integrity
Integrity underpins all operations at Intuitive Surgical, ensuring transparency and accountability in its business practices. The company adheres to high ethical standards in its engagements with customers, stakeholders, and regulatory bodies.
In 2024, Intuitive Surgical faced several product liability lawsuits, and the company is actively defending against these claims while maintaining its commitment to product safety and customer trust. The legal expenses associated with these cases are closely monitored to ensure they do not compromise the company's financial health, which reported a net income of $565.1 million for Q3 2024, a significant increase from $415.7 million in Q3 2023.
Core Value: Collaboration
Collaboration is essential for fostering partnerships that enhance surgical practices and improve patient outcomes. Intuitive Surgical engages with healthcare professionals and institutions to refine its products and services continually.
In 2024, the company placed 379 da Vinci surgical systems, which included 110 of the new da Vinci 5 systems, indicating strong collaboration with hospitals and surgeons to meet their evolving needs. This collaborative approach has resulted in a growing installed base of approximately 9,539 da Vinci systems, a 15% increase from the previous year.
Core Value: Excellence
Excellence in product quality and customer service is a hallmark of Intuitive Surgical's operations. The company strives to maintain high standards in all aspects of its business, from manufacturing to customer support.
The gross profit margin for Q3 2024 was reported at 67.4%, up from 66.9% in Q3 2023, showcasing the company's efficient operations and commitment to delivering high-quality products. Furthermore, Intuitive Surgical's dedication to excellence is reflected in its customer satisfaction ratings and the increasing number of procedures performed using its systems.
Core Value: Respect
Respect for individuals and communities is fundamental to Intuitive Surgical's corporate culture. The company emphasizes respect in its interactions with employees, customers, and the communities it serves.
In 2024, Intuitive Surgical reported $2.04 billion in total revenue for Q3, representing a 17% increase year-over-year, driven by strong demand for its products and services. This financial success allows the company to contribute to community health initiatives and support educational programs to promote surgical innovation and training.
| Core Value | Description | 2024 Metrics |
|---|---|---|
| Innovation | Commitment to advancing surgical technology | $286 million R&D expense; 670,000 da Vinci procedures |
| Integrity | Adherence to ethical standards and transparency | $565.1 million net income; ongoing product liability defense |
| Collaboration | Partnerships with healthcare professionals | 379 systems placed; 15% increase in installed base |
| Excellence | High standards in product quality and service | 67.4% gross profit margin |
| Respect | Valuing individuals and communities | $2.04 billion total revenue; community health initiatives |
Intuitive Surgical, Inc. (ISRG) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Intuitive Surgical, Inc. (ISRG) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Intuitive Surgical, Inc. (ISRG)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Intuitive Surgical, Inc. (ISRG)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.